WO2003106972A3 - MULTI-DOMAIN COMPOUNDS OF TDF, MULTI-DOMAIN PARENTS AND THEIR ANALOGS - Google Patents

MULTI-DOMAIN COMPOUNDS OF TDF, MULTI-DOMAIN PARENTS AND THEIR ANALOGS Download PDF

Info

Publication number
WO2003106972A3
WO2003106972A3 PCT/US2003/019229 US0319229W WO03106972A3 WO 2003106972 A3 WO2003106972 A3 WO 2003106972A3 US 0319229 W US0319229 W US 0319229W WO 03106972 A3 WO03106972 A3 WO 03106972A3
Authority
WO
WIPO (PCT)
Prior art keywords
domain
tdf
analogs
parents
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/019229
Other languages
French (fr)
Other versions
WO2003106972A2 (en
Inventor
William D Carlson
Peter C Keck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thrasos Inc
Original Assignee
Thrasos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrasos Inc filed Critical Thrasos Inc
Priority to AU2003276752A priority Critical patent/AU2003276752A1/en
Publication of WO2003106972A2 publication Critical patent/WO2003106972A2/en
Publication of WO2003106972A3 publication Critical patent/WO2003106972A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention porte sur d'une manière générale sur des analogues du facteur de différenciation des tissus (TDF), et plus spécifiquement sur des procédés et compositions basés sur des structures permettant de désigner, identifier et produire des molécules agissant en tant que modulateurs fonctionnels de récepteurs analogues du TDF. L'invention porte également sur des procédés de détection, prévention et traitement de troubles associés au TDF.The invention relates generally to tissue differentiation factor (TDF) analogs, and more specifically to structure-based methods and compositions for designating, identifying, and producing molecules that act as functional modulators. analog TDF receptors. The invention also relates to methods of detecting, preventing and treating disorders associated with TDF.

PCT/US2003/019229 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof Ceased WO2003106972A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003276752A AU2003276752A1 (en) 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US38948602P 2002-06-17 2002-06-17
US38949002P 2002-06-17 2002-06-17
US60/389,486 2002-06-17
US60/389,490 2002-06-17
US44172403P 2003-01-22 2003-01-22
US60/441,724 2003-01-22
US45885103P 2003-03-28 2003-03-28
US45872703P 2003-03-28 2003-03-28
US60/458,727 2003-03-28
US60/458,851 2003-03-28

Publications (2)

Publication Number Publication Date
WO2003106972A2 WO2003106972A2 (en) 2003-12-24
WO2003106972A3 true WO2003106972A3 (en) 2004-09-30

Family

ID=29741151

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/019229 Ceased WO2003106972A2 (en) 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof

Country Status (2)

Country Link
AU (1) AU2003276752A1 (en)
WO (1) WO2003106972A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005265098B2 (en) * 2004-06-17 2012-02-23 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
AU2012200042B2 (en) * 2004-06-17 2015-03-26 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
AU2006292147B2 (en) * 2005-09-20 2013-03-07 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
AU2012201060B2 (en) * 2005-09-20 2015-01-22 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CELESTE A.J. ET AL: "Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE OF THE USA, vol. 87, no. 24, December 1990 (1990-12-01), WASHINGTON, DC, US, pages 9843 - 9847, XP000168624 *

Also Published As

Publication number Publication date
AU2003276752A8 (en) 2003-12-31
AU2003276752A1 (en) 2003-12-31
WO2003106972A2 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
FR21C1031I2 (en) N4-PHENYL-QUINAZOLIN-4-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS ERBB KINASE TYROSINE TYPE I INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
WO2006009836A3 (en) Tdf-related compounds and analogs thereof
MA30555B1 (en) METHODS OF USING THE GPR119 RECEPTOR TO IDENTIFY COMPOUNDS USEFUL IN INCREASING BONE MASS IN AN INDIVIDUAL
BRPI0410746A (en) immunosuppressive compounds and compositions
BRPI0410741B8 (en) immunosuppressive compound, its pharmaceutical composition, and its uses
MA30888B1 (en) COMPOSITIONS AND METHODS FOR MODULATING C-KIT RECEPTORS AND PLATELET DERIVED GROWTH FACTOR (PDGFR)
NO20010446L (en) Substituted anilide compounds and methods
BRPI0413326A (en) methods for treating cardiovascular disease by employing a soluble ctla4 molecule
DE69914726D1 (en) COMPOSITION FOR REGULATING THE SKIN APPEARANCE
MA35460B1 (en) Compounds and compositions as c-kit kinase inhibitors
BR0309576A (en) Factor vii (fvii) or factor viia (fviia) polypeptide variant, nucleotide sequence, expression vector, host cell, pharmaceutical composition, use of a variant, and method for treating a mammal having a disease or disorder in that clot formation is desirable
BR9812659A (en) Elastometric compositions and processes for producing them
EP0813545A4 (en) NUCLEOTID AND PROTEIN SEQUENCES OF A SERRATE GENE FROM VERBELTIEREN AND METHODS THEREFORE
MXPA06014721A (en) Novel alkynyl derivatives as modulators of metabotropic glutamate receptors.
BRPI0407401A (en) bicyclic compounds and compositions
ATE549311T1 (en) AMINO-PROPANOL DERIVATIVES AS MODULATORS OF THE SPHINGOSINE-1 PHOSPHATE RECEPTOR
CY1116742T1 (en) COMPOUNDS RELATING TO TDF AND THEIR analogues
CY1110417T1 (en) TRYPTAMINE DERIVATIVES AND RELATED COMPOUNDS AND PHARMACEUTICAL FORMS CONTAINING THESE
Fogarty et al. Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro
BR0311783A (en) Condensed Palatinose and Method to Produce the Same
WO2003106972A3 (en) MULTI-DOMAIN COMPOUNDS OF TDF, MULTI-DOMAIN PARENTS AND THEIR ANALOGS
MA32968B1 (en) Substituted quinazoline compounds
WO2003105772A3 (en) PARATHYROID HORMONE ANALOGS AND PARATHYROID HORMONE-RELATED PROTEIN AS BONE ANABOLIZING AGENTS
Inagaki et al. Type-2 astrocytes show intracellular Ca2+ elevation in response to various neuroactive substances
BRPI0418727A (en) spinning nonwoven from polymer fibers and their application

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP